These benefits, along with a previous report displaying that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the concept of targeting ACKR3 as a novel technique to modulate the opioid method, which could open up new therapeutic avenues for opioid-linked Problems.A fresh examine demonstrates which the compound